LncRNA-CRNDE-h is also abundant in tumor exosomes and participates in tumor progression by mediating ubiquitination and degradation of RORγt, promoting Th17-cell differentiation and affecting the activity of the IL-17 promoter (99). The gene discussed is IL17A; the disease is neoplasm.